Cargando…
Efficacy of stereotactic ablative radiotherapy (SABR) during anti-PD-1 in oligoprogressive non-small cell lung cancer and melanoma—a prospective multicenter observational study pointing out new unmet needs
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080467/ https://www.ncbi.nlm.nih.gov/pubmed/37033340 http://dx.doi.org/10.21037/tcr-22-2841 |
_version_ | 1785020929269563392 |
---|---|
author | Damen, Pim J. J. Verhoeff, Joost J. C. |
author_facet | Damen, Pim J. J. Verhoeff, Joost J. C. |
author_sort | Damen, Pim J. J. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10080467 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-100804672023-04-08 Efficacy of stereotactic ablative radiotherapy (SABR) during anti-PD-1 in oligoprogressive non-small cell lung cancer and melanoma—a prospective multicenter observational study pointing out new unmet needs Damen, Pim J. J. Verhoeff, Joost J. C. Transl Cancer Res Editorial Commentary AME Publishing Company 2023-02-27 2023-03-31 /pmc/articles/PMC10080467/ /pubmed/37033340 http://dx.doi.org/10.21037/tcr-22-2841 Text en 2023 Translational Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Editorial Commentary Damen, Pim J. J. Verhoeff, Joost J. C. Efficacy of stereotactic ablative radiotherapy (SABR) during anti-PD-1 in oligoprogressive non-small cell lung cancer and melanoma—a prospective multicenter observational study pointing out new unmet needs |
title | Efficacy of stereotactic ablative radiotherapy (SABR) during anti-PD-1 in oligoprogressive non-small cell lung cancer and melanoma—a prospective multicenter observational study pointing out new unmet needs |
title_full | Efficacy of stereotactic ablative radiotherapy (SABR) during anti-PD-1 in oligoprogressive non-small cell lung cancer and melanoma—a prospective multicenter observational study pointing out new unmet needs |
title_fullStr | Efficacy of stereotactic ablative radiotherapy (SABR) during anti-PD-1 in oligoprogressive non-small cell lung cancer and melanoma—a prospective multicenter observational study pointing out new unmet needs |
title_full_unstemmed | Efficacy of stereotactic ablative radiotherapy (SABR) during anti-PD-1 in oligoprogressive non-small cell lung cancer and melanoma—a prospective multicenter observational study pointing out new unmet needs |
title_short | Efficacy of stereotactic ablative radiotherapy (SABR) during anti-PD-1 in oligoprogressive non-small cell lung cancer and melanoma—a prospective multicenter observational study pointing out new unmet needs |
title_sort | efficacy of stereotactic ablative radiotherapy (sabr) during anti-pd-1 in oligoprogressive non-small cell lung cancer and melanoma—a prospective multicenter observational study pointing out new unmet needs |
topic | Editorial Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080467/ https://www.ncbi.nlm.nih.gov/pubmed/37033340 http://dx.doi.org/10.21037/tcr-22-2841 |
work_keys_str_mv | AT damenpimjj efficacyofstereotacticablativeradiotherapysabrduringantipd1inoligoprogressivenonsmallcelllungcancerandmelanomaaprospectivemulticenterobservationalstudypointingoutnewunmetneeds AT verhoeffjoostjc efficacyofstereotacticablativeradiotherapysabrduringantipd1inoligoprogressivenonsmallcelllungcancerandmelanomaaprospectivemulticenterobservationalstudypointingoutnewunmetneeds |